OMRIX biopharmaceuticals OMRIX biopharmaceuticals
Sitemap Email   Go  
Facilities
 

Facilities

 
 

OMRIX is headquartered at 1120 Avenue of the Americas, 4th Floor, New York, NY 10036. Research & Development and Manufacturing are located in Tel Aviv, Israel.

OMRIX believes that its current production capacity is sufficient to meet its present output requirements. The Company plans to expand its production capacity by building a new production facility in Jerusalem, Israel. The new facility is expected to be complete in 2009, and the additional production capacity will allow the Company to meet its supply demands for the foreseeable future after 2009.

 
About Us
 
   
terms of use | privacy policy | contact us | sitemap | prescribing info